FIBROBLAST GROWTH FACOTR RECEPTOR

SOURCE – Tyra Biosciences, Inc. – In a preclinical HCH model, TYRA-300 demonstrated increases in long bone length and binding against the HCH altered protein–  -TYRA remains on track to submit ACH Investigational…